From: Loryjean Pratt <loryoils@gmail.com>
To: everythingdoterra@googlegroups.com
Sent: Wed, October 28, 2009 9:47:48 AM
Subject: [Everything doTERRA] Re: Dr. Mercola's plagerized statements on Flu Shots
When one quotes the source, it is not plagarism. Dr. Mercola, like Dr.
Oz, Dr. Phil, and everyone else, has an opinion and an agenda. This is
why it is important to get your information from more than one
"source", so that you can be knowledgeable and discern truth from
error.
Loryjean
On 10/28/09,
jcm899@aol.com <
jcm899@aol.com> wrote:
>
>
>
> You might find this very interesting....and follow the link at the end as
> well,
> Jan In Florida <><
>
>
>
> 10.28.2009
>
>
>
> Dr Mercola, a MD, states on
> an email I received from a friend:
>
>
>
> "A study published in
> the Lancet just found that influenza vaccination was NOT
> associated with a reduced risk of pneumonia in older people. Why is this
> important? Because 35,000 of the 36,000 "flu" deaths the government claims
> happen each year are actually caused by diseases like pneumonia, and NOT the
> flu
>
>
>
> ·
> Giving young children
> flu shots appeared to have no impact on flu-related doctor visits or
> hospitalizations during two recent flu seasons, according to a study
> published
> in the October issue of the Archives of Pediatric &
> Adolescent Medicine. This link opens up Dr
> Mercola's website.
>
>
>
> ·
> The flu vaccine is no
> more effective for children than a placebo, according to a large-scale,
> systematic review of 51 studies,
> published in the Cochrane Database of Systematic
> Reviews. Dr Mercola is plagiarizing this information. See the actual
> study abstract below.
>
>
>
> ·
> NO studies have conclusively proven that flu shots prevent flu-related
> deaths among
> the elderly. For this statement, Dr
> Mercola is quoting his own website.
>
>
>
> ·
> A study published in the Lancet just found that influenza vaccination was
> NOT
> associated with a reduced risk of pneumonia in older people. Why is this
> important? Because 35,000 of the 36,000 "flu" deaths the government claims
> happen
> each year are actually caused by diseases like pneumonia, and NOT the flu.
> Again, DrMercola is plagiarizing the information,
> as pneumonia is a consequence of influenza, as the medical profession knows.
>
>
>
> ·
> Research published in
> the American Journal of Respiratory and
> Critical Care Medicine
> also confirms that there has been no decrease in deaths from influenza and
> pneumonia, despite the fact that vaccination coverage among the elderly has
> increased from 15 percent in 1980 to 65 percent now. Please read the
> original study abstract below. The
> red highlights are mine.
>
>
>
>
>
>
> For even more information, studies and
> statistics about the flu shot, please review this previous article."
>
>
>
>
>
>
>
>
>
>
> My (Jeannie
> Boyle) investigation reveals the following, using the links supplied by Dr
> Mercola: (red highlights are added by me)
>
>
>
> Vaccines
> for preventing influenza in healthy children.Smith
> S, Demicheli V,
> Di Pietrantonj C,
> Harnden AR,
> Jefferson T,
> Matheson NJ,
> Rivetti A.
>
>
>
> Oxford University, Institute of Health
> Sciences, Old Road Headington, Oxford, UK, OX3 7LF.
>
sue.smith@public-health.oxford.ac.uk> BACKGROUND: In children and adults the consequences of influenza are
> mainly absences from school and work, however the risk of complications is
> greatest in children and people over 65 years old. OBJECTIVES: To appraise
> all
> comparative studies evaluating the effects of influenza vaccines in healthy
> children; assess vaccine efficacy (prevention of confirmed influenza) and
> effectiveness (prevention of influenza-like illness) and document adverse
> events associated with receiving influenza vaccines. SEARCH STRATEGY: We
> searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The
> Cochrane Library Issue 1, 2005); OLD MEDLINE (1966 to 1969); MEDLINE (1969
> to
> December 2004); EMBASE (1974 to December 2004); Biological Abstracts (1969
> to
> December 2004); and Science Citation Index (1974 to December 2004). We wrote
> to
> vaccine manufacturers and a number of corresponding authors of studies in
> the
> review. SELECTION CRITERIA: Any randomised controlled trials (RCTs), cohort
> and
> case-control studies of any influenza vaccine in healthy children under 16
> years
> old. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial
> quality and extracted data. MAIN RESULTS: Fifty-one studies involving
> 263,987
> children were included. Seventeen papers were translated from Russian.
> Fourteen
> RCTs and 11 cohort studies were included in the analysis of vaccine efficacy
> and effectiveness. From RCTs, live vaccines showed an efficacy of 79% (95%
> confidence interval (CI) 48% to 92%) and an effectiveness of 33% (95% CI 28%
> to
> 38%) in children older than two years compared with placebo or no
> intervention.
> Inactivated vaccines had a lower efficacy of 59% (95% CI 41% to 71%) than
> live
> vaccines but similar effectiveness: 36% (95% CI 24% to 46%). In children
> under
> two, the efficacy of inactivated vaccine was similar to placebo. Thirty-four
> reports containing safety outcomes were included, 22 including live
> vaccines, 8
> inactivated vaccines and 4 both types. The most commonly presented
> short-term
> outcomes were temperature and local reactions. The variability in design of
> studies
> and presentation of data was such that meta-analysis of safety outcome data
> was
> not feasible. AUTHORS' CONCLUSIONS: Influenza
> vaccines are efficacious in children older than two years but little
> evidence
> is available for children under two. There
> was a marked difference between vaccine efficacy and effectiveness. That no
> safety comparisons could be carried out emphasizes the need for
> standardisation
> of methods and presentation of vaccine safety data in future studies. It was
> surprising to find only one study of inactivated vaccine in children under
> two
> years, given recent recommendations to vaccinate healthy children from six
> months old in the USA and Canada. If immunisation in children is to be
> recommended as public-health policy, large-scale studies assessing important
> outcomes and directly comparing vaccine types are urgently required.
>
>
>
>
>
>
> PMID: 16437500 [PubMed - indexed
> for MEDLINE
>
>
>
>
>
>
> The Dr Oz link displays:
> "PAGE NOT FOUND" –Here Dr Mercola is providing a dead-end
> link.
>
>
>
> ______________________________________________________________________________
>
>
>
>
> Am J
> Respir Crit Care Med. 2008 Sep 1;178(5):527-33. Epub 2008 Jun 12. Mortality
> reduction with
> influenza vaccine in patients with pneumonia outside "flu" season:
> pleiotropic benefits or residual confounding? Eurich
> DT, Marrie
> TJ, Johnstone
> J, Majumdar
> SR. Department of Public Health Sciences, School of Public Health,
> University of Alberta, 13-103 Clinical Sciences Bldg., Edmonton, AB, T6G 2G3
> Canada.
deurich@ualberta.ca Comment in: Am J
> Respir Crit Care Med. 2008 Sep 1;178(5):439-40.
>
>
>
> RATIONALE: Observational studies
> suggest a 50% mortality reduction for older patients receiving influenza
> vaccination; some deem this magnitude of benefit implausible and invoke
> confounding by the "healthy user effect" as an alternate explanation.
> OBJECTIVES: To evaluate unrecognized confounding by hypothesizing the
> presence
> of a 50% mortality reduction with vaccination for patients with pneumonia
> outside of
> influenza season. METHODS: Clinical, laboratory, and functional data were
> prospectively collected on 1,813 adults with community-acquired pneumonia
> admitted to six hospitals outside of influenza season in the Capital Health
> region (AB, Canada). Vaccination status was ascertained by interview and
> chart
> review. Outcome
> was in-hospital mortality. Influenza-vaccinated patients were
> matched to a nonvaccinated control using propensity scores, and then
> multivariable regression was used to determine the independent association
> between vaccination and mortality. MEASUREMENTS AND MAIN RESULTS: The cohort
> consisted of 352 vaccine recipients and 352 matched control subjects. Most
> (85%) patients were 65 years or older, 29% had severe pneumonia, and 12%
> died. Influenza
> vaccination was associated with a 51% mortality reduction (28 of 352 [8%]
> died
> vs. 53 of 352 [15%] control subjects; unadjusted odds ratio [OR],
> 0.49; 95% confidence interval [CI], 0.30-0.79; P = 0.004) outside influenza
> season. Adjustment for age, sex, and comorbidities did not alter these
> findings
> (adjusted OR, 0.45; 95% CI, 0.27-0.76). More complete adjustment for
> confounding (e.g., functional and socioeconomic status) markedly attenuated
> these benefits and their statistical significance (adjusted OR, 0.81; 95%
> CI,
> 0.35-1..85; P = 0.61). CONCLUSIONS: The 51% reduction in mortality with
> vaccination initially observed in patients with pneumonia who did not have
> influenza was most likely a result of confounding. Previous observational
> studies may have overestimated mortality benefits of influenza vaccination.
>
>
>
>
>
>
> PMID: 18556629 [PubMed - indexed for
> MEDLINE]
>
>
>
>
>
>
> Please have a look at the link below:
>
>
>
> http://www.quackwatch.org/04ConsumerEducation/nonrecperiodicals.html
>
>
>
> >
>
